A detailed history of Bourgeon Capital Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bourgeon Capital Management LLC holds 3,507 shares of ABBV stock, worth $820,638. This represents 0.14% of its overall portfolio holdings.

Number of Shares
3,507
Holding current value
$820,638
% of portfolio
0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

BUY
$211.96 - $244.38 $743,343 - $857,040
3,507 New
3,507 $820,000
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $33,024 - $37,192
240 Added 240.0%
340 $52,000
Q4 2022

Jan 20, 2023

BUY
$138.31 - $165.87 $13,831 - $16,587
100 New
100 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bourgeon Capital Management LLC Portfolio

Follow Bourgeon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bourgeon Capital Management LLC with notifications on news.